Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 43 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 30 | 1,254−7.9%/yr | −7.9%/yr | 3.21.0× | 7% | 1,220 in 2030−0.4%/yr |
| Lumbar fusion | 24 | 751−6.1%/yr | −6.1%/yr | 1.90.6× | 5% | 730 in 2030−0.5%/yr |
| Kyphoplasty & vertebroplasty | 11 | 674−8.7%/yr | −8.7%/yr | 1.81.0× | 37% | 540 in 2030−3.7%/yr |
| Cervical fusion & disc arthroplasty | 15 | 594−6.2%/yr | −6.2%/yr | 1.50.9× | 5% | 650 in 2030+1.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 132 | 29,280−1.7%/yr | −1.7%/yr | 74.30.6× | 32% | 33,700 in 2030+2.4%/yr |
| Skin substitutes & wound grafts | 17 | 4,095+20%/yr | +20%/yr | 7.10.6× | 73% | 6,940 in 2030+9.2%/yr |
| Bone graft & orthobiologics | 8 | 484−8.7%/yr | −8.7%/yr | 1.21.8× | 2% | 370 in 2030−4.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 73 | 7,188−5.6%/yr | −5.6%/yr | 18.31.3× | 76% | 7,600 in 2030+0.9%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 21 | 852+4.7%/yr | +4.7%/yr | 2.11.5× | 57% | 980 in 2030+2.4%/yr |
| Spinal cord & DRG stimulation | 11 | 302−2.5%/yr | −2.5%/yr | 0.70.8× | 51% | 330 in 2030+1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 23 | 2,979−1.4%/yr | −1.4%/yr | 7.61.2× | 45% | 2,520 in 2030−2.8%/yr |
| Dialysis access | 13 | 1,246−12%/yr | −12%/yr | 3.40.6× | 62% | 1,150 in 2030−1.3%/yr |
| Superficial venous ablation | 11 | 666−14%/yr | −14%/yr | 1.70.3× | 78% | 580 in 2030−2.1%/yr |
| Thrombectomy, IVC filters & venous stents | 6 | 614+8.4%/yr | +8.4%/yr | 1.60.9× | 5% | 680 in 2030+1.8%/yr |
| Carotid revascularization | 13 | 532−8.8%/yr | −8.8%/yr | 1.41.1× | 0% | 550 in 2030+0.4%/yr |
| Aortic endografts (EVAR/TEVAR) | 6 | 201−3.4%/yr | −3.4%/yr | 0.51.1× | 0% | 170 in 2030−3.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cholecystectomy & appendectomy | 59 | 2,014−6.1%/yr | −6.1%/yr | 5.51.2× | 3% | 1,900 in 2030−0.9%/yr |
| Hernia repair | 21 | 2,007−3.9%/yr | −3.9%/yr | 5.60.9× | 7% | 2,270 in 2030+2.1%/yr |
| Colorectal resection | 3 | 698−6%/yr | −6%/yr | 1.91.1× | 0% | 680 in 2030−0.3%/yr |
| Antireflux & hiatal hernia surgery | 1 | 248−7.6%/yr | −7.6%/yr | 0.70.8× | 0% | 260 in 2030+0.6%/yr |
| Bariatric surgery | 2 | 119−15%/yr | −15%/yr | 0.31.7× | 0% | 70 in 2030−8.4%/yr |
| Breast reconstruction | 0 | 111−8.5%/yr | −8.5%/yr | 0.30.6× | 0% | 50 in 2030−13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 37 | 1,786−2.9%/yr | −2.9%/yr | 4.80.9× | 10% | 1,850 in 2030+0.6%/yr |
| BPH procedures | 29 | 1,636−4.1%/yr | −4.1%/yr | 4.30.9× | 35% | 1,550 in 2030−0.9%/yr |
| Incontinence, prolapse & sacral neuromodulation | 21 | 1,234−4.1%/yr | −4.1%/yr | 3.21.2× | 30% | 1,060 in 2030−2.6%/yr |
| Hysterectomy, hysteroscopy & ablation | 6 | 815−2%/yr | −2%/yr | 2.30.9× | 14% | 780 in 2030−0.7%/yr |
| Prostatectomy & nephrectomy | 7 | 393−2.1%/yr | −2.1%/yr | 1.10.9× | 0% | 480 in 2030+3.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 7 | 620−8.4%/yr | −8.4%/yr | 1.70.3× | 69% | 890 in 2030+6.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 39 | 2,201−3.4%/yr | −3.4%/yr | 6.20.9× | 36% | 2,190 in 2030−0.1%/yr |
| Tumor & fibroid embolization | 3 | 165−1.3%/yr | −1.3%/yr | 0.40.8× | 73% | 740 in 2030+29%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 47 | 10,160+31%/yr | +31%/yr | 26.50.9× | 84% | 16,600 in 2030+8.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 40 | 2,434−5.8%/yr | −5.8%/yr | 6.71.2× | 0% | 2,160 in 2030−1.9%/yr |
| EP ablation | 15 | 1,494+3.9%/yr | +3.9%/yr | 3.40.9× | 0% | 2,460 in 2030+8.7%/yr |
| LAA occlusion & loop recorders | 24 | 1,335+7.5%/yr | +7.5%/yr | 3.10.9× | 0% | 2,590 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 86 | 4,691−7.9%/yr | −7.9%/yr | 10.41.8× | 2% | 4,440 in 2030−0.9%/yr |
| Structural heart (TAVR, TEER) | 31 | 553+0.7%/yr | +0.7%/yr | 1.30.8× | 0% | 420 in 2030−4.4%/yr |
| Mechanical circulatory support | 0 | 234−12%/yr | −12%/yr | 0.61.1× | 0% | 250 in 2030+1.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 6 | 127−8.9%/yr | −8.9%/yr | 0.30.8× | 0% | 150 in 2030+2.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 64 | 19,041−6%/yr | −6%/yr | 49.60.8× | 87% | 22,100 in 2030+2.5%/yr |
| Vitreoretinal surgery | 10 | 687−6.8%/yr | −6.8%/yr | 1.80.7× | 0% | 580 in 2030−2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 152 | 33,269−5.9%/yr | −5.9%/yr | 91.10.8× | 50% | 32,200 in 2030−0.5%/yr |
| Bronchoscopy & lung nodule | 16 | 1,036−1.8%/yr | −1.8%/yr | 2.80.8× | 0% | 1,540 in 2030+6.9%/yr |
| ERCP & endoscopic ultrasound | 12 | 721−1.7%/yr | −1.7%/yr | 1.90.6× | 0% | 990 in 2030+5.4%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.